Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -0.14% is 100% above its 5-year average of -85.34%, near the high end of its 5-year range (-266.16%–11.66%).
97.24% above its 12-month average of -5.07%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4.23%.
EBITDA MARGIN
-0.14%
EBITDA MARGIN AVG TTM
-5.07%
EBITDA MARGIN AVG 3Y
-6.52%
EBITDA MARGIN AVG 5Y
-85.34%
EBITDA MARGIN AVG 10Y
-170.37%
EBITDA MARGIN AVG 15Y
-168.56%
EBITDA MARGIN AVG 20Y
-261.48%
CURRENT VS TTM AVG
+97.24%
CURRENT VS 3Y AVG
+97.85%
CURRENT VS 5Y AVG
+99.84%
CURRENT VS 10Y AVG
+99.92%
CURRENT VS 15Y AVG
+99.92%
CURRENT VS 20Y AVG
+99.95%
Heron Therapeutics, Inc.
Market Cap
$62.56M
EBITDA Margin
-0.14%
TTM Avg
-5.07%
3Y Avg
-6.52%
5Y Avg
-85.34%
Market Cap
$63.07M
EBITDA Margin
-1113.80%
TTM Avg
-13312.72%
3Y Avg
-13312.72%
5Y Avg
-13312.72%
Market Cap
$63.16M
EBITDA Margin
-11538.23%
TTM Avg
-6406.80%
3Y Avg
-3544.47%
5Y Avg
-2835.62%
Market Cap
$63.56M
EBITDA Margin
-46.36%
TTM Avg
-44.45%
3Y Avg
-49.00%
5Y Avg
-37.18%
Market Cap
$61.34M
EBITDA Margin
-99843.01%
TTM Avg
-70984.01%
3Y Avg
-70984.01%
5Y Avg
-70984.01%
Market Cap
$61.01M
EBITDA Margin
-16170.91%
TTM Avg
-8243.87%
3Y Avg
-8243.87%
5Y Avg
-8243.87%
Market Cap
$64.83M
EBITDA Margin
-334.74%
TTM Avg
-191.68%
3Y Avg
-191.68%
5Y Avg
-191.68%
Market Cap
$60.23M
EBITDA Margin
-753.96%
TTM Avg
-753.96%
3Y Avg
-753.96%
5Y Avg
-753.96%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $62.56M | -0.14% | -5.07% | -6.52% | -85.34% |
| RenovoRx, Inc. (RNXT)vs › | $63.07M | -1113.80% | -13312.72% | -13312.72% | -13312.72% |
| InterCure Ltd. (INCR)vs › | $63.19M | 8.84% | -6.43% | -1.20% | -7.11% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | -11538.23% | -6406.80% | -3544.47% | -2835.62% |
| Alps Group Inc (ALPS)vs › | $63.56M | -46.36% | -44.45% | -49.00% | -37.18% |
| Fractyl Health, Inc. (GUTS)vs › | $61.34M | -99843.01% | -70984.01% | -70984.01% | -70984.01% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.01M | -16170.91% | -8243.87% | -8243.87% | -8243.87% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.83M | -334.74% | -191.68% | -191.68% | -191.68% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.23M | -753.96% | -753.96% | -753.96% | -753.96% |
| XBiotech Inc. (XBIT)vs › | $65.88M | -794.91% | -458.44% | -317.77% | -317.77% |
Gross Margin
70.1%
EBITDA Margin
-0.1%
Operating Margin
-7.2%
Net Margin
-22.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -4.23% |
| 2026-03-31 | -12.20% |
| 2025-12-31 | 2.96% |
| 2025-09-30 | -9.10% |
| 2025-06-30 | -2.76% |
| 2025-03-31 | 9.52% |
| 2024-12-31 | 11.66% |
| 2024-09-30 | -11.82% |
| 2024-06-30 | -16.11% |
| 2024-03-31 | -11.85% |
| 2023-12-31 | -27.77% |
| 2023-09-30 | -76.99% |
| 2023-06-30 | -131.18% |
| 2023-03-31 | -109.22% |
| 2022-12-31 | -65.15% |
| 2022-09-30 | -155.05% |
| 2022-06-30 | -176.72% |
| 2022-03-31 | -265.17% |
| 2021-12-31 | -255.35% |
| 2021-09-30 | -219.35% |
| 2021-06-30 | -266.16% |
| 2021-03-31 | -256.64% |
| 2020-12-31 | -294.03% |
| 2020-09-30 | -288.58% |
| 2020-06-30 | -242.65% |
| 2020-03-31 | -205.17% |
| 2019-12-31 | -167.60% |
| 2019-09-30 | -80.55% |
| 2019-06-30 | -139.90% |
| 2019-03-31 | -203.26% |
| 2018-12-31 | -176.45% |
| 2018-09-30 | -209.23% |
| 2018-06-30 | -222.97% |
| 2018-03-31 | -446.17% |
| 2017-12-31 | -611.81% |
| 2017-09-30 | -477.24% |
| 2017-06-30 | -489.34% |
| 2017-03-31 | -1348.29% |
| 2016-12-31 | -3635.42% |
| 2016-09-30 | -7175.49% |
| 2012-12-31 | -118.28% |
| 2011-06-30 | -595.22% |
| 2011-03-31 | -320.76% |
| 2010-12-31 | -940.78% |
| 2010-09-30 | -450.14% |
| 2010-06-30 | -686.60% |
| 2010-03-31 | -1163.49% |
| 2009-12-31 | -1650.82% |
| 2009-09-30 | -100.72% |
| 2009-06-30 | -27664.29% |
| 2009-03-31 | -35925.00% |
| 2008-12-31 | -17757.14% |
| 2008-09-30 | -9642.19% |
| 2008-06-30 | -4041.45% |
| 2008-03-31 | -5254.89% |
| 2007-12-31 | -5854.55% |
| 2007-06-30 | -2515.63% |
| 2005-12-31 | -164.61% |
| 2005-06-30 | -202.24% |
| 2005-03-31 | -88.38% |
| 2004-12-31 | -155.67% |
| 2004-09-30 | -129.22% |
| 2004-06-30 | -182.71% |
| 2004-03-31 | -214.41% |
| 2003-12-31 | -106.26% |
| 2003-09-30 | -85.57% |
| 2003-06-30 | -165.00% |
| 2003-03-31 | -160.94% |
| 2002-12-31 | -14.75% |
| 2002-09-30 | -107.07% |
